Powered by Business Wire
Search Results for Topix.net

MD Buyline Releases Q2.2014 User Satisfaction Trending™ Data

Clinical and financial experts shed light on market trending and real-world, end-user feedback

DALLAS--(BUSINESS WIRE)--MD Buyline announced today its Q2.2014 User Satisfaction Trending™ data is now available to MD Buyline members. By conducting end-user interviews, MD Buyline’s industry experts evaluate real-world experiences with capital equipment and vendors’ service. Market trending, end-user ratings and customer feedback help MD Buyline members compare and select their next medical technology investment.

“Breast Cancer Screening Using Tomosynthesis in Combination With Digital Mammography”

While keeping a pulse on customer experiences, MD Buyline’s experts also analyze healthcare market trends, such as emerging technologies, recalls issued by the Food and Drug Administration (FDA) and studies published by medical journals.

One technology that experienced notable market visibility and activity is the mammography system. In a Market Intelligence Briefing report, which includes User Satisfaction Trending data, MD Buyline clinical analyst Rachael Bennett provided insight into mammogram market trends, including differences between 3-D and 2-D tomosynthesis systems, lack of existing vendor competition and absence of a dedicated reimbursement code for 3-D.

Additionally, mammography systems have received recent attention due to the study “Breast Cancer Screening Using Tomosynthesis in Combination With Digital Mammography” published in the Journal of the American Medical Association. Ms. Bennett was interviewed by several national, leading news sources, including The Wall Street Journal, Associated Press, Bloomberg, The Boston Globe and MIT Technology Review, because of her expertise in mammography systems.

The study showed Hologic’s 3-D mammogram system (a vendor and technology covered by MD Buyline’s User Satisfaction Trending data) when paired with traditional digital mammography was more effective at finding breast cancers than traditional scans alone. Following the release of the study, Siemens Healthcare announced it submitted an application to the FDA for its 3-D breast tomosynthesis system. The Wall Street Journal interviewed Ms. Bennett again for her competitive intel of the mammogram market.

MD Buyline members have access to clinical and financial insight from MD Buyline’s experts, including Ms. Bennett, and evidence-based technology reports, including User Satisfaction Trending.

About User Satisfaction Trending

For more than 30 years, MD Buyline has been researching medical technologies to create transparency between healthcare providers and medical technology suppliers. This in-depth and dynamic data enables MD Buyline’s clinical analysts to map trending for ratings and end-user feedback on technologies and suppliers. MD Buyline members can review User Satisfaction Trending data on more than 100 medical technologies through MD Buyline’s online portal of proprietary clinical research. For more information or to speak with an analyst, contact MD Buyline at 1-800-375-5463 or send an email to info@mdbuyline.com.

About MD Buyline

Healthcare providers recognize MD Buyline as the leading provider of evidence-based information and research. By creating transparency and fostering consultative relationships, MD Buyline has partnered with providers for more than three decades to identify cost reduction opportunities for purchased services, consumables, capital and IT. Providers rely on MD Buyline’s data and clinical analysts for financial and clinical insight to reach long- and short-term goals. For more information, please visit www.mdbuyline.com, and follow MD Buyline on Twitter, @MDBuyline.

Contacts

MD Buyline
Lindsay Peabody
214-891-6738
Lindsay.Peabody@mdbuyline.com